info icon

This is a non-core endpoint: only basic statistics are computed.

ILD medications: acetylcysteine

ILD_ASETYLCYSTEINE

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC R05CB01

1 out of 7 registries used, show all original rules.

303

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

303

diagram downward connector

Include endpoints None

303

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

293

diagram downward connector
ILD_ASETYLCYSTEINE

Control definitions

Control exclude ILD_MEDICATIONS

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 293 114 179
Unadjusted prevalence (%) 0.08 0.05 0.11
Mean age at first event (years) 60.93 52.58 66.24

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: ILD_ASETYLCYSTEINE – ILD medications: acetylcysteine
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after ILD medications: acetylcysteine

Endpoint not on priority list, no data to show.